CAPRICOR THERAPEUTICS, INC. Cash and Restricted Cash
CAPRICOR THERAPEUTICS, INC. (CAPR) had Cash and Restricted Cash of $20.94 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.94M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $105.42M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $287.85M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.51M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $20.94M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $105.42M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $287.85M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $19.51M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $23.24M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $28.79M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $11.29M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $68.38M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $10.69M 10-Q · filed 2025-08-11 |
| 2024-03-31 | $6.21M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $14.69M 10-K · filed 2026-03-17 |
| 2023-09-30 | $8.98M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $9.84M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $10.61M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $9.60M 10-K · filed 2025-03-26 |
| 2022-09-30 | $8.41M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $16.39M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $58.33M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $34.89M 10-K · filed 2024-03-11 |
| 2021-09-30 | $40.84M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $38.08M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $41.88M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $32.67M 10-K · filed 2023-03-17 |
| 2020-09-30 | $35.30M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $36.25M 10-Q · filed 2021-08-13 |
| 2020-03-31 | $13.22M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $3.90M 10-K · filed 2022-03-11 |
| 2019-09-30 | $7.06M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $6.12M 10-Q · filed 2020-08-10 |
| 2019-03-31 | $7.36M 10-Q · filed 2020-05-15 |
| 2018-12-31 | $4.55M 10-K · filed 2021-03-15 |
| 2018-09-30 | $4.80M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $6.87M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $7.79M 10-Q · filed 2019-05-14 |
| 2017-12-31 | $6.88M 10-K · filed 2020-03-27 |
| 2017-09-30 | $9.51M 10-Q · filed 2018-11-14 |
| 2017-06-30 | $9.09M 10-Q · filed 2018-08-13 |
| 2017-03-31 | $3.88M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $4.55M 10-K · filed 2019-03-29 |
| 2016-09-30 | $18.62M 10-Q · filed 2017-11-14 |
| 2016-06-30 | $8.85M 10-Q · filed 2017-08-14 |
| 2015-12-31 | $5.57M 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |